ScholarWorks@Hanyang University: Pai, Hyun joo

Detailed Information

Pai, Hyun joo (배현주)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 감염내과

Tel 02-2290-8356
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Korea:9||Clostridium difficile:6||Urinary tract infection:6||Acute pyelonephritis:5||Pyelonephritis:4||Escherichia coli:4||Klebsiella pneumoniae:4||Resistance:3||Minimum inhibitory concentration:3||Epidemiology:3||Risk factor:3||Clostridioides difficile:3||Antibiotic consumption:3||Pneumonia:3||Diabetes mellitus:3||Antimicrobial resistance:3||antibiotics:3||Tigecycline:2||fluoroquinolone:2||South Korea:2||Aortic aneurysm:2||Treatment:2||Liver abscess:2||Communityacquired infections:2||Clinical characteristics:2||MLVA:2||Antimicrobial susceptibility test:2||antibiotic resistance genes:2||Antibiotics:2||Antibacterial agents:2||Pyomyositis:2||Clostridium difficile infection:2||Antibiotic:2||stewardship:2||gut microbiome:2||Stewardship:2||PCR ribotype:2||Guideline:2||Community:1||Community acquired:1||CommunityAcquired Infections:1||Concomitant medication:1||Cystitis:1||DHA1:1||Dengue fever:1||Diagnosis:1||Diagnostic imaging:1||Drug resistance:1||E:1||Enterobacteriaceae:1||Extendedspectrum betalactamase:1||Extendedspectrum cephalosporins:1||Extrapulmonary:1||Fever:1||Fosfomycin:1||Glycylcycline:1||HIV:1||Health care worker:1||Healthcare associated infection:1||Herpes Zoster Vaccine:1||Hospital Management:1||Hospitalization:1||Hospitals:1||Human immunodeficiency virus:1||Human immunodeficiency virus (HIV):1||Humans:1||Immunocompetent:1||Immunology:1||Incidence:1||Infection:1||Intensive care unit:1||Interferongamma release assay:1||Intervention:1||Latent tuberculosis infection:1||MIC:1||Maculopathy:1||Male:1||Medical costs:1||Megaloblastic anemia:1||Metronidazole:1||Minimal Inhibitory Concentration:1||Mycobacterium fortuitum:1||National Data:1||National Health Insurance:1||National health insurance:1||Nationwide outbreak:1||Nephrotoxicity:1||Nitrofurantoin:1||Nodular:1||PCR ribotype 018:1||PCR ribotyping:1||Piperacillin/tazobactam:1||Plasmidmediated:1||Plasmidmediated quinolone resistance:1||Pneumocystis jirovecii:1||Polymyxin E:1||Porphyromonas pogonae:1||Practice guideline:1||Quinolone resistance:1||Rapidly growing mycobacteria:1||Recurrent:1||Republic of Korea:1||Ribotype:1||Ribotyping:1||Risk factors:1||SHV12:1||ST131:1||Shigella sonnei:1||Skin and skin structure infection:1||Soft tissue infection:1||Susceptibility:1||Susceptibility testing media:1||Temocillin:1||Tomography scanners Xray computed:1||Toxin Type:1||Trauma:1||TrimethoprimSulfamethoxazole combination:1||Tuberculin skin test:1||Ultrasonography:1||Urinary Tract:1||Vancomycin:1||Vitamin B12:1||Women:1||acute pyelonephritis:1||adult:1||aminoglycoside:1||antibiotic resistance:1||antimicrobial stewardship:1||bacterial composition:1||betaLactamase:1||cephalosporins:1||children:1||chronic obstructive pulmonary diseases:1||coli:1||correlation:1||early clinical failure:1||education:1||epidemiology:1||ermB gene:1||genetic relatedness:1||hospitalacquired infection:1||infection control:1||intervention studies:1||medical student:1||mobilome:1||multilocus variablenumber tandemrepeat analysis:1||piperacillin/tazobactam:1||plasmid:1||pyelonephritis:1||reinfection:1||recurrence:1||relapse:1||resistance:1||respiratory infection:1||ribotype:1||ribotype 017:1||risk factor:1||spread:1||statistical model:1||tcdAnegative variant strain:1||treatment:1||urinary tract infection:1||2015:1||viral infection:1||AIDS:1||Acinetobacter baumannii:1||Acinetobacter infections:1||Acquired immune deficiency syndrome:1||Acute Pyelonephritis:1||Adrenal Insufficiency:1||Adverse Effects:1||Aged:1||AmpC betalactamase:1||Anaerobe:1||Antibacterial agents:1||Antibiotic Consumption:1||Antibiotic usage:1||Antimicrobial:1||Antimicrobial susceptibility:1||Antimicrobials:1||Antiviral:1||Attributable Cost:1||Atypical:1||Bacillary dysentery:1||Binary toxin:1||Blood culture:1||Bursitis:1||CSSSI:1||Catheterassociated bloodstream infections:1||Cefepime:1||Ciprofloxacin:1||Clinical Characteristics:1||Clinical features:1||Clinical outcome:1||Clostridioides difficile Infection:1||Clostridioides difficile infection:1||Clostridioides difficile infections:1||Clostridium difficile Infection:1||Colistin:1||Colonization:1||Combination drug therapy:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE